Literature DB >> 30159798

Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1 channel in an in vitro seizure model.

Mustafa Nazıroğlu1,2, Afife Nur Taner3, Esra Balbay3, Bilal Çiğ4.   

Abstract

The expression level of TRPV1 is high in hippocampus which is a main epileptic area in the brain. In addition to the actions of capsaicin (CAP) and reactive oxygen species (ROS), the TRPV1 channel is activated in neurons by endogenous cannabinoid, anandamide (AEA). In the current study, we investigated the role of inhibitors of TRPV1 (capsazepine, CPZ), AEA transport (AM404), and FAAH (URB597) on the modulation of Ca2+ entry, apoptosis, and oxidative stress in in vitro seizure-induced rat hippocampus and human glioblastoma (DBTRG) cell line. The seizure was induced in the hippocampal and DBTRG neurons using in vitro 4-aminopyridine (4-AP) to trigger a seizure-like activity model. CPZ and AM404 were fully effective in reversing 4-AP-induced intracellular free Ca2+ concentration of the hippocampus and TRPV1 current density of DBTRG. However, AEA and CAP did not activate TRPV1 in the URB597-treated neurons. Hence, we observed TRPV1 blocker effects of URB597 in the DBTRG neurons. In addition, the AM404 and CPZ treatments decreased intracellular ROS production, mitochondrial membrane depolarization, apoptosis, caspases 3 and 9 values in the hippocampus. In conclusion, the results indicate that inhibition of AEA transport, FAAH synthesis, and TRPV1 activity can result in remarkable neuroprotective effects in the epileptic neurons. Possible molecular pathways of involvement of capsazepine (CPZ) and AM4040 in anandamide and capsaicin (CAP)-induced apoptosis, oxidative stress, and Ca2+ accumulation through TRPV1 channel in the seizure-induced rat hippocampus and human glioblastoma neurons. The TRPV1 channel is activated by different stimuli including reactive oxygen species (ROS), anandamide (AEA), and CAP and it is blocked by capsazepine (CPZ). Cannabinoid receptor type 1 (CB1) is also activated by AEA. The AEA levels in cytosol are decreased by fatty acid amide hydrolase (FAAH) enzyme. Inhibition of FAAH through URB597 induces stimulation of CB1 receptor through accumulation AEA. URB597 acts antiepileptic effects through inhibition of TRPV1. Overloaded Ca2+ concentration of mitochondria can induce an apoptotic program by stimulating the release of apoptosis-promoting factors such as caspases 3 and caspase 9 by generating ROS due to respiratory chain damage. AM404 and CPZ reduce TRPV1 channel activation and Ca2+ entry in the in vitro 4-AP seizure model-induced hippocampal and glioblastoma neurons.

Entities:  

Keywords:  Anandamide; Apoptosis; Epilepsy; FAAH inhibition; Oxidative stress; TRPV1

Mesh:

Substances:

Year:  2018        PMID: 30159798     DOI: 10.1007/s11010-018-3439-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  11 in total

Review 1.  Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder.

Authors:  Mariah M Wu; Xinwen Zhang; Melissa J Asher; Stanley A Thayer
Journal:  Brain Res       Date:  2019-09-17       Impact factor: 3.252

Review 2.  Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Authors:  Vamsi Reddy; Dayton Grogan; Meenakshi Ahluwalia; Évila Lopes Salles; Pankaj Ahluwalia; Hesam Khodadadi; Katelyn Alverson; Andy Nguyen; Srikrishnan P Raju; Pankaj Gaur; Molly Braun; Fernando L Vale; Vincenzo Costigliola; Krishnan Dhandapani; Babak Baban; Kumar Vaibhav
Journal:  EPMA J       Date:  2020-04-15       Impact factor: 6.543

3.  Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish.

Authors:  Cammi Thornton; Kennedy E Dickson; Dennis R Carty; Nicole M Ashpole; Kristine L Willett
Journal:  Epilepsy Behav       Date:  2020-06-22       Impact factor: 2.937

4.  The Endocannabinoid System May Modulate Sleep Disorders in Aging.

Authors:  Eric Murillo-Rodríguez; Henning Budde; André Barciela Veras; Nuno Barbosa Rocha; Diogo Telles-Correia; Diogo Monteiro; Luis Cid; Tetsuya Yamamoto; Sérgio Machado; Pablo Torterolo
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

5.  Neuroprotective Effect of AM404 Against NMDA-Induced Hippocampal Excitotoxicity.

Authors:  Soraya Wilke Saliba; Tiziana Bonifacino; Tsvetan Serchov; Giambattista Bonanno; Antônio Carlos Pinheiro de Oliveira; Bernd L Fiebich
Journal:  Front Cell Neurosci       Date:  2019-12-20       Impact factor: 5.505

6.  URB597 Prevents the Short-Term Excitotoxic Cell Damage in Rat Cortical Slices: Role of Cannabinoid 1 Receptors.

Authors:  Karla Chavira-Ramos; Mario Orozco-Morales; Çimen Karasu; Alexey A Tinkov; Michael Aschner; Abel Santamaría; Ana Laura Colín-González
Journal:  Neurotox Res       Date:  2020-11-03       Impact factor: 3.911

7.  TRPV1 Contributes to the Neuroprotective Effect of Dexmedetomidine in Pilocarpine-Induced Status Epilepticus Juvenile Rats.

Authors:  Xingqin Tan; Yong Zeng; Zhenzhen Tu; Pan Li; Hengsheng Chen; Li Cheng; Shengfen Tu; Li Jiang
Journal:  Biomed Res Int       Date:  2020-04-07       Impact factor: 3.411

Review 8.  Insights into Potential Targets for Therapeutic Intervention in Epilepsy.

Authors:  Cecilia Zavala-Tecuapetla; Manola Cuellar-Herrera; Hiram Luna-Munguia
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

9.  The protective role of selenium against dental amalgam-induced intracellular oxidative toxicity through the TRPV1 channel in DBTRG glioblastoma cells.

Authors:  Derya Ceyhan; Kadriye Gorkem Ulu Guzel; Bilal Cig
Journal:  J Appl Oral Sci       Date:  2021-02-10       Impact factor: 2.698

Review 10.  The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets.

Authors:  Rosa Maria Vitale; Fabio Arturo Iannotti; Pietro Amodeo
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.